VAN ECK ASSOCIATES CORP – Vertex Pharmaceuticals Incorporated Transaction History
VAN ECK ASSOCIATES CORP portfolio value:
$50.71M
portfolio value
VAN ECK ASSOCIATES CORP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +8.85% | 14.23K shares | 5.37M | $289.54 | 175.17K |
| Q2 2022 | share | Increase | +11.19% | 16.20K shares | 7.57M | $281.79 | 160.93K |
| Q1 2022 | share | Decrease | -9.27% | -14.79K shares | 2.73M | $260.97 | 144.73K |
| Q4 2021 | share | Decrease | -10.97% | -19.65K shares | 2.53M | $222.45 | 159.52K |
| Q3 2021 | share | Increase | +26.81% | 37.88K shares | 4.01M | $181.39 | 179.17K |
| Q2 2021 | share | Increase | +16.88% | 20.40K shares | 2.51M | $201.63 | 141.29K |
| Q1 2021 | share | Increase | +7.87% | 8.81K shares | -510K | $214.89 | 120.89K |
| Q4 2020 | share | Increase | +11.92% | 11.93K shares | -761K | $236.34 | 112.07K |
| Q3 2020 | share | Decrease | -5.15% | -5.44K shares | -3.40M | $272.12 | 100.13K |
| Q2 2020 | share | Increase | +41.25% | 30.83K shares | 12.86M | $290.31 | 105.57K |
| Q1 2020 | share | Decrease | -17.02% | -15.32K shares | -1.93M | $237.95 | 74.74K |
| Q4 2019 | share | Decrease | -13.46% | -14.01K shares | 2.08M | $218.95 | 90.07K |
| Q3 2019 | share | Decrease | -6.07% | -6.72K shares | -2.68M | $169.42 | 104.08K |
| Q2 2019 | share | Decrease | -4.82% | -5.61K shares | -1.09M | $183.38 | 110.81K |
| Q1 2019 | share | Increase | +1.02% | 1.17K shares | 2.31M | $183.95 | 116.42K |
| Q4 2018 | share | Decrease | -10.86% | -14.04K shares | -5.82M | $165.71 | 115.25K |
| Q3 2018 | share | Decrease | -7.58% | -10.60K shares | 1.14M | $192.74 | 129.30K |
| Q2 2018 | share | Increase | +5.11% | 6.79K shares | 2.08M | $169.96 | 139.90K |
| Q1 2018 | share | Decrease | -29.92% | -56.83K shares | -6.77M | $162.98 | 133.10K |
| Q4 2017 | share | Decrease | -8.39% | -17.38K shares | -3.05M | $149.86 | 189.94K |
| Q3 2017 | share | Decrease | -10.69% | -24.81K shares | 1.60M | $152.04 | 207.33K |
| Q2 2017 | share | Decrease | -31.09% | -104.71K shares | -6.91M | $128.87 | 232.14K |
| Q1 2017 | share | Decrease | -1.09% | -3.72K shares | 11.74M | $109.35 | 336.86K |
| Q4 2016 | share | Increase | +20.85% | 58.75K shares | 512K | $73.67 | 340.58K |
| Q3 2016 | share | Increase | +9.92% | 25.43K shares | 2.52M | $87.21 | 281.83K |
| Q2 2016 | share | Decrease | -5.32% | -14.40K shares | 530K | $86.02 | 256.40K |
| Q1 2016 | share | Increase | +7.48% | 18.85K shares | -10.17M | $79.49 | 270.80K |